Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pill aims to tame COPD Flare-Ups in Year-Long test

NCT ID NCT07349524

Summary

This study is testing whether a new tablet called RSS0343 can help control Chronic Obstructive Pulmonary Disease (COPD). It will involve about 237 adults with COPD who have experienced recent flare-ups. The main goal is to see if the pill, taken for 48 weeks, can reduce the frequency of these serious breathing episodes compared to a placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, 510140, China

    Contact

Conditions

Explore the condition pages connected to this study.